Brenner West Capital Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-172,229
Closed -$36.2M 21
2016
Q4
$36.2M Sell
172,229
-31,120
-15% -$6.45M 3.99% 9
2016
Q3
$46.8M Sell
203,349
-67,551
-25% -$16.5M 4.19% 12
2016
Q2
$62.6M Sell
270,900
-67,214
-20% -$15.5M 5.45% 7
2016
Q1
$90.6M Buy
338,114
+49,217
+17% +$14.1M 7.13% 6
2015
Q4
$90.3M Buy
+288,897
New +$86M 9.51% 6

Other funds holding AGN

Brenner West Capital Advisors's AGN Position: Q1 2017 in Review

Brenner West Capital Advisors sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 172,229 shares — an estimated $36.2M sold.

Brenner West Capital Advisors first reported a position in AGN in Q4 2015 and held it in 5 quarters. The position peaked at $90.6M in Q1 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Brenner West Capital Advisors reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Brenner West Capital Advisors sold 172,229 Allergan plc shares in Q1 2017, an estimated $36.2M.
  • Brenner West Capital Advisors first reported a position in Allergan plc in Q4 2015 and held it in 5 quarters.
  • Brenner West Capital Advisors's Allergan plc position peaked at $90.6M in Q1 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Brenner West Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.